regulatory path for bronchitol established, page-4

Trial be done in combo with European regulators. Expected to begin late 2008, 52 week trial and 300 patients. That would mean reporting early 2010 I guess (not stated), but it reads like the trial carries with it pre-approval from FDA that the elements meet their critieria for approval should the trial be a success. Guess this is good news (europe and US covered in one hit). Some time to go, but there's now some certainty in the way forward for this. Is that how others read this? Hopefully the market likes the news.